These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24778037)
1. Expression of Pdcd4 tumor suppressor in human melanoma cells. Vikhreva PN; Korobko IV Anticancer Res; 2014 May; 34(5):2315-8. PubMed ID: 24778037 [TBL] [Abstract][Full Text] [Related]
2. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349 [TBL] [Abstract][Full Text] [Related]
3. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells. Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270 [TBL] [Abstract][Full Text] [Related]
4. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Gao F; Zhang P; Zhou C; Li J; Wang Q; Zhu F; Ma C; Sun W; Zhang L Oncol Rep; 2007 Jan; 17(1):123-8. PubMed ID: 17143488 [TBL] [Abstract][Full Text] [Related]
5. Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors. Kalinichenko SV; Kopantzev EP; Korobko EV; Palgova IV; Zavalishina LE; Bateva MV; Petrov AN; Frank GA; Sverdlov ED; Korobko IV Lung Cancer; 2008 Nov; 62(2):173-80. PubMed ID: 18457901 [TBL] [Abstract][Full Text] [Related]
7. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells. Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533 [TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma. Wang X; Wei Z; Gao F; Zhang X; Zhou C; Zhu F; Wang Q; Gao Q; Ma C; Sun W; Kong B; Zhang L Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945 [TBL] [Abstract][Full Text] [Related]
9. mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells. Vikhreva PN; Shepelev MV; Korobko IV Biochim Biophys Acta; 2014 Jan; 1839(1):43-9. PubMed ID: 24334141 [TBL] [Abstract][Full Text] [Related]
10. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
11. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461 [TBL] [Abstract][Full Text] [Related]
12. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma. Woodard J; Sassano A; Hay N; Platanias LC Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479 [TBL] [Abstract][Full Text] [Related]
13. Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion. González-Villasana V; Nieves-Alicea R; McMurtry V; Gutiérrez-Puente Y; Tari AM Oncol Rep; 2012 Mar; 27(3):861-6. PubMed ID: 22200873 [TBL] [Abstract][Full Text] [Related]
14. Distinct roles of different fragments of PDCD4 in regulating the metastatic behavior of B16 melanoma cells. Wang D; Guo S; Han SY; Xu N; Guo JY; Sun Q Int J Oncol; 2013 May; 42(5):1725-33. PubMed ID: 23450345 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900 [TBL] [Abstract][Full Text] [Related]
16. [Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer]. Ma G; Guo KJ; Zhang H; Ozaki I; Matsuhashi S; Zheng XY; Dong M Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):597-600. PubMed ID: 16274040 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line. Lankat-Buttgereit B; Müller S; Schmidt H; Parhofer KG; Gress TM; Göke R Biol Cell; 2008 Dec; 100(12):703-15. PubMed ID: 18549351 [TBL] [Abstract][Full Text] [Related]
18. Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators. Leupold JH; Asangani IA; Mudduluru G; Allgayer H Biosci Rep; 2012 Jun; 32(3):281-97. PubMed ID: 22111549 [TBL] [Abstract][Full Text] [Related]
19. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Schmid T; Jansen AP; Baker AR; Hegamyer G; Hagan JP; Colburn NH Cancer Res; 2008 Mar; 68(5):1254-60. PubMed ID: 18296647 [TBL] [Abstract][Full Text] [Related]
20. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]